Silvina Gallo

2.0k total citations · 1 hit paper
14 papers, 1.5k citations indexed

About

Silvina Gallo is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Silvina Gallo has authored 14 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in Silvina Gallo's work include Metabolism, Diabetes, and Cancer (12 papers), Diabetes Treatment and Management (12 papers) and Diabetes Management and Research (5 papers). Silvina Gallo is often cited by papers focused on Metabolism, Diabetes, and Cancer (12 papers), Diabetes Treatment and Management (12 papers) and Diabetes Management and Research (5 papers). Silvina Gallo collaborates with scholars based in United States, Germany and United Kingdom. Silvina Gallo's co-authors include Steven G. Terra, Susan Huyck, B Charbonnel, James P. Mancuso, Darren K. McGuire, Weichung Shih, Christopher P. Cannon, Richard E. Pratley, Urszula Masiukiewicz and Francesco Cosentino and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and Diabetes.

In The Last Decade

Silvina Gallo

14 papers receiving 1.4k citations

Hit Papers

Cardiovascular Outcomes with Ertugliflozin in Type 2 Diab... 2020 2026 2022 2024 2020 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
    2020 1.0k citations Christopher P. Cannon, Richard E. Pratley et al. New England Journal of Medicine profile →

Peers

Silvina Gallo
Stefan Kaspers Germany
Heidrun Bosch‐Traberg Denmark
Bruce R. Leslie United States
Albert Fung United States
Mark Warren United States
Robert Edwards United States
Gabriel Kim Germany
Nora Fagan United States
Lin Ping United States
Ambady Ramachandran India
Stefan Kaspers Germany
Silvina Gallo
Citations per year, relative to Silvina Gallo Silvina Gallo (= 1×) peers Stefan Kaspers

Countries citing papers authored by Silvina Gallo

Since Specialization
Citations

This map shows the geographic impact of Silvina Gallo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvina Gallo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvina Gallo more than expected).

Fields of papers citing papers by Silvina Gallo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvina Gallo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvina Gallo. The network helps show where Silvina Gallo may publish in the future.

Co-authorship network of co-authors of Silvina Gallo

This figure shows the co-authorship network connecting the top 25 collaborators of Silvina Gallo. A scholar is included among the top collaborators of Silvina Gallo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvina Gallo. Silvina Gallo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Lingvay, Ildiko, et al.. (2021). Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy. Diabetes Obesity and Metabolism. 23(7). 1640–1651. 9 indexed citations
3.
Gallo, Silvina, Annaswamy Raji, Roberto A. Calle, Annpey Pong, & Christian Meyer. (2020). The effects of ertugliflozin on β‐cell function: Pooled analysis from four phase 3 randomized controlled studies. Diabetes Obesity and Metabolism. 22(12). 2267–2275. 3 indexed citations
4.
Gallo, Silvina, Roberto A. Calle, Steven G. Terra, et al.. (2020). Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials. Diabetes Therapy. 11(8). 1849–1860. 10 indexed citations
5.
Cannon, Christopher P., Richard E. Pratley, Samuel Dagogo‐Jack, et al.. (2020). Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes. New England Journal of Medicine. 383(15). 1425–1435. 1011 indexed citations breakdown →
6.
Heymsfield, Steven B., Annaswamy Raji, Silvina Gallo, et al.. (2020). Efficacy and Safety of Ertugliflozin in Patients with Overweight and Obesity with Type 2 Diabetes Mellitus. Obesity. 28(4). 724–732. 14 indexed citations
7.
Liu, Jie, Annpey Pong, Silvina Gallo, Amanda Darekar, & Steven G. Terra. (2019). Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials. Cardiovascular Diabetology. 18(1). 59–59. 18 indexed citations
8.
Liu, Jie, Lisa Tarasenko, Steven G. Terra, et al.. (2019). Efficacy of ertugliflozin in monotherapy or combination therapy in patients with type 2 diabetes: A pooled analysis of placebo-controlled studies. Diabetes and Vascular Disease Research. 16(5). 415–423. 22 indexed citations
9.
Gallo, Silvina, B Charbonnel, Harry Shi, et al.. (2019). Long‐term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104‐week VERTIS MET trial. Diabetes Obesity and Metabolism. 21(4). 1027–1036. 53 indexed citations
10.
Cannon, Christopher P., Darren K. McGuire, Richard E. Pratley, et al.. (2018). DESIGN AND BASELINE CHARACTERISTICS OF THE EVALUATION OF ERTUGLIFOZIN EFFICACY AND SAFETY CARDIOVASCULAR OUTCOMES TRIAL (VERTIS-CV). Journal of the American College of Cardiology. 71(11). A1825–A1825. 55 indexed citations
11.
Cannon, Christopher P., Darren K. McGuire, Richard E. Pratley, et al.. (2018). Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV). American Heart Journal. 206. 11–23. 160 indexed citations
12.
Hickman, Mary A., Robert Frederich, Shrita M. Patel, et al.. (2018). Evaluation of Fractures, Bone Mineral Density (BMD), and Bone Biomarkers in Patients with Type 2 Diabetes Mellitus (T2DM) Receiving Ertugliflozin. Diabetes. 67(Supplement_1). 4 indexed citations
13.
14.
Minocha, A, et al.. (1994). Alterations in upper gastrointestinal motility in Helicobacter pylori-positive nonulcer dyspepsia.. PubMed. 89(10). 1797–800. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Kaspers Breakdown of academic impact, for papers by Heidrun Bosch‐Traberg Breakdown of academic impact, for papers by Bruce R. Leslie Breakdown of academic impact, for papers by Albert Fung Breakdown of academic impact, for papers by Mark Warren Breakdown of academic impact, for papers by Robert Edwards Breakdown of academic impact, for papers by Gabriel Kim Breakdown of academic impact, for papers by Nora Fagan Breakdown of academic impact, for papers by Lin Ping Breakdown of academic impact, for papers by Ambady Ramachandran
Rankless by CCL
2026